Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.
about
Toward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinomaStrategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantationOutcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting listWaiting time and explant pathology in transplant recipients with hepatocellular carcinoma: a novel study using national data.Standardizing MELD Exceptions: Current Challenges and Future DirectionsTime to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm.Delta-slope of alpha-fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer.Comparison of two equivalent MELD scores for hepatocellular carcinoma patients using data from the United Network for Organ Sharing liver transplant waiting list registry.Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteriaPretransplant Locoregional Therapy for Hepatocellular Carcinoma: Evaluation of Explant Pathology and Overall Survival.Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.Hepatocellular carcinoma in patients listed for liver transplantation: Current and future allocation policy and management strategies for the individual patient.Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging?Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma.Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.Excellent Outcomes of Liver Transplantation Following Down Staging of Hepatocellular Carcinoma to Within Milan Criteria-a Multi-Center Study.Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot".Conundrum of treatment for early-stage hepatocellular carcinoma: radiofrequency ablation instead of liver transplantation as the first-line treatment?Selecting patients with hepatocellular carcinoma for liver transplantation: who should receive priority?Liver-directed therapy for hepatocellular carcinoma.Bridging to liver transplantation in HCC patients.Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.The Impact of Bridging LRT on Survival in Patients Listed for Liver Transplantation.Surgical Treatment of Hepatocellular Carcinoma.Transplantation for hepatocellular cancer: pushing to the limits?
P2860
Q26999411-31084F5F-C8A6-429C-B7C3-0C40B6C4B1F2Q27005375-59D5D49A-1391-42DB-B7BA-D9838ECC478FQ28649715-1E8B13A3-D516-41ED-8426-47D07D51A3A1Q30829251-BF5EFB44-2411-4A00-A28F-D305454EFE3BQ34712729-A8D1AFA5-EA04-4168-9956-958F245E0F13Q35384660-6FC90C48-8EC1-4917-9F58-D2EDEADC046CQ35482821-4484A4CB-236E-49B7-B410-39C154813A81Q36278672-AE22B6FD-3E36-45C1-9163-7A9CFC8F4703Q36345076-CE59D947-5155-49E7-9927-EDE5D2AFA15AQ36716640-C3668AF1-0EA7-4B4C-B075-0D82D9400EB3Q36728731-75F47211-1773-497D-B53E-4F18B19DA05AQ36733226-A371113A-AC7B-4EB8-92FF-A45DA7835306Q36995679-4B6C41C0-F963-4283-99D5-C3318696C72DQ37348887-5A8A6C7C-B523-45B3-B64C-0DEAAEC22368Q38604896-E0AF88F8-5F23-4C9D-A1B7-D543D951C0B7Q38631276-672E117A-0003-47A7-A976-79D5148E4AA9Q38707454-6AAA3EEA-ACC2-402A-B221-3F5700EBF0B1Q38821374-B3A0E6F6-0E41-4332-BC54-8720F31A1781Q39067623-BFC9F867-5FFB-4540-800A-8158AB4BB0EEQ41650892-E49CF729-02A0-4746-B95A-7A8FBA6EF330Q41669686-395FF268-8965-4A00-BB38-0D4006B52A0FQ45325696-0E8914A2-278D-4536-B270-0497E5EB7032Q46145394-29374C6E-CA6B-4A40-ABB7-E7870671EAD6Q46456307-5FEE3E18-84AC-4746-B81C-21D922419386Q46554324-60751F7C-1FB1-446F-B8CB-5936D443E457Q46665396-5F59ECE2-D1C0-439C-BF2B-E4B13E1AD618Q46800739-580F1995-3F7E-41EA-B0A2-5A7FAAF7D258Q48326665-C0ED6090-40B9-416B-B1B3-1C1DBD7C45B6Q50244078-F85CC18F-8D1F-4B89-8A8F-9A4F3A4C1340Q50500971-0EA8C431-0BCE-4EB4-811C-A2C341340F62Q54989355-46876C90-5C7E-4EA5-B77C-448A9EDF081BQ58554770-602A5EF4-754A-444B-9394-DC7C746475C6
P2860
Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of liver transp ...... rrent organ allocation policy.
@en
Identification of liver transp ...... rrent organ allocation policy.
@nl
type
label
Identification of liver transp ...... rrent organ allocation policy.
@en
Identification of liver transp ...... rrent organ allocation policy.
@nl
prefLabel
Identification of liver transp ...... rrent organ allocation policy.
@en
Identification of liver transp ...... rrent organ allocation policy.
@nl
P2093
P2860
P356
P1476
Identification of liver transp ...... rrent organ allocation policy.
@en
P2093
Aparna Goel
Francis Y Yao
Jennifer L Dodge
John Paul Roberts
Neil Mehta
Ryutaro Hirose
P2860
P304
P356
10.1002/LT.23753
P577
2013-12-01T00:00:00Z